Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (431-440 of 569) with videos related to

Pageof 57
Sort By:
Cancers|November 18, 2020
Tumor MHC Expression Guides First-Line Immunotherapy Selection in MelanomaElena Shklovskaya, Jenny H Lee, Su Yin Lim, et al.
Annals of Surgical Oncology|May 12, 2005
Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsyVivian S K Yee, John F Thompson, J Gregory McKinnon, et al.
The New England Journal of Medicine|September 29, 2006
Sentinel-node biopsy or nodal observation in melanomaDonald L Morton, John F Thompson, Alistair J Cochran, et al.
Annals of Surgical Oncology|July 9, 2010
The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)Mark B Faries, John F Thompson, Alistair Cochran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical TrialsJarem Edwards, Annie Tasker, Inês Pires da Silva, et al.
Frontiers in Immunology|August 25, 2022
Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcomeGrace H Attrill, Hansol Lee, Annie T Tasker, et al.
Annals of Surgical Oncology|October 12, 2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma MetastasesMark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 22, 2017
Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral centerAlexander H R Varey, Chris Goumas, Angela M Hong, et al.
Genome Research|August 2, 2011
True single-molecule DNA sequencing of a pleistocene horse boneLudovic Orlando, Aurelien Ginolhac, Maanasa Raghavan, et al.
Cancers|July 2, 2021
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic TargetsTuba N Gide, Inês Pires da Silva, Camelia Quek, et al.
Pageof 57

Showing results (431-440 of 569) with videos related to

Sort By:
Pageof 57
Cancers|November 18, 2020
Tumor MHC Expression Guides First-Line Immunotherapy Selection in MelanomaElena Shklovskaya, Jenny H Lee, Su Yin Lim, et al.
Annals of Surgical Oncology|May 12, 2005
Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsyVivian S K Yee, John F Thompson, J Gregory McKinnon, et al.
The New England Journal of Medicine|September 29, 2006
Sentinel-node biopsy or nodal observation in melanomaDonald L Morton, John F Thompson, Alistair J Cochran, et al.
Annals of Surgical Oncology|July 9, 2010
The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)Mark B Faries, John F Thompson, Alistair Cochran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical TrialsJarem Edwards, Annie Tasker, Inês Pires da Silva, et al.
Frontiers in Immunology|August 25, 2022
Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcomeGrace H Attrill, Hansol Lee, Annie T Tasker, et al.
Annals of Surgical Oncology|October 12, 2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma MetastasesMark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 22, 2017
Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral centerAlexander H R Varey, Chris Goumas, Angela M Hong, et al.
Genome Research|August 2, 2011
True single-molecule DNA sequencing of a pleistocene horse boneLudovic Orlando, Aurelien Ginolhac, Maanasa Raghavan, et al.
Cancers|July 2, 2021
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic TargetsTuba N Gide, Inês Pires da Silva, Camelia Quek, et al.
Pageof 57